Efficacy of nonavalent human papillomavirus vaccine for recalcitrant warts
Ital J Dermatol Venerol
.
2023 Feb;158(1):67-68.
doi: 10.23736/S2784-8671.22.07380-7.
Authors
Caterina Dianzani
1
,
Nicoleta Neagu
2
,
Aldo Venuti
3
,
Giulia Coscarella
1
,
Benedetta DE Franciscis
1
,
Francesco Montini
1
,
Iris Zalaudek
4
,
Claudio Conforti
4
Affiliations
1
Unit of Plastic and Reconstructive Surgery, Campus Bio-Medico University, Rome, Italy.
2
Department of Epidemiology, George Emil Palade University of Medicine, Pharmacy, Science and Technology, Târgu Mureș, Romania -
[email protected]
.
3
HPV-Unit, UOSD Tumor Immunology and Immunotherapy, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
4
Department of Dermatology, Maggiore Hospital, University of Trieste, Trieste, Italy.
PMID:
36939508
DOI:
10.23736/S2784-8671.22.07380-7
No abstract available
MeSH terms
Human Papillomavirus Viruses
Humans
Papillomavirus Infections* / prevention & control
Papillomavirus Vaccines* / therapeutic use
Warts* / therapy
Substances
Papillomavirus Vaccines